HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries

This Week in 340B: September 12 – 19, 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation.

Issues at Stake: 340B Covered Entity

  • A medical group filed an antitrust case in Pennsylvania federal court against a 340B covered entity.
  • In a case involving the definition of “patient”, the covered entity filed a reply brief.
  • The covered entity appellant in a Ninth Circuit case filed its opening brief against the prime vendor program appellee.

Get more details on these 340B cases with the 340B Litigation Tracker, a subscription product from McDermott+Consulting.




Top Takeaways | Specialty Spotlight: Gastroenterology

In this moderated session featuring perspectives from top gastroenterology (GI) executives, panelists explored the thriving state of marketing and dealmaking in this field.

Session panelists included:

  • Robbie Allen, Chief Executive Officer, One GI
  • Matt Devine, Chief Executive Officer, Allied Digestive Health
  • Michael Kroin, Chief Executive Officer and managing partner, Physician Growth Partners
  • Samuel Vaill, Chief Development Officer, United Digestive
  • Moderator: Amanda Jester, Partner, McDermott Will & Emery

Top takeaways included:

  1. Gastroenterology continues to be an attractive specialty for investment. This is due to a number of factors, including gastroenterology’s diverse revenue streams that can provide income repair for physicians and generate alignment among stakeholders. The increased push for outpatient surgical care to lower costs of care and the decreasing age of patients seeking colonoscopies and other gastroenterology procedures provide investors with significant runways to drive growth.
  2. As labor costs increase and challenges in the healthcare industry continue, physician practice management organizations provide gastroenterology groups with economies of scale, the ability to develop ancillaries and strong recruiting programs, as well as leverage against disruption by payors, hospital systems and competitors. Other advantages include access to expansive clinical data for research and development and improved point-of-care support.
  3. Culture is an oft-overlooked factor in gastroenterology transactions. Because transactions are intended to foster long-term arrangements, ensuring cultural alignment is key for the future success of a platform. Physicians should also consider the ways in which the platform focuses on the physician and the support of their practice as well as the [...]

    Continue Reading



An International Guide to Regulatory and Transactional Issues

In today’s rapidly evolving global healthcare landscape, market participants encounter a wealth of potential alongside a diverse range of challenges. We understand the importance of negotiating complex and ever-shifting regulations efficiently when structuring cross-border investments and transactions.

In our Guide, you’ll discover invaluable insights to help navigate the dynamic world of healthcare, unlocking opportunities and understanding the developing regulatory landscape.

Download the guide here!




Investing In a Healthier Future: The Investor’s Perspective On Value-Based Care

In this session, McDermott Will & Emery Partner Joel Rush moderated a discussion exploring investors’ interests in, opinions on and strategies for entering the value-based care (VBC) market. The panel discussed factors taken into consideration when choosing if and when to invest in VBC opportunities, issues that arise when collaborating with health systems, and ways to evaluate risk models and support improved care delivery.

Session panelists included:

  • Lauren Brueggen, Partner, Heritage Group
  • Devin Carty, Chief Executive Officer, Martin Ventures
  • Roger Kueny, Senior Vice President of Corporate Development, Alignment
  • David Pontius, Partner, WindRose Health Investors
  • Karey Witty, Managing Director, Valtruis

Top takeaways included:

  1. When it comes to investing in VBC, the tailwinds are just beginning to pick up after the COVID-19 pandemic reduced reimbursement volume. During that time, physician practices that were leaning on fee-for-service (FFS) reimbursements saw their volumes drop close to zero during the COVID-19 pandemic. Hospitals began to get crushed by the rates, and much of the volume has yet to return to normal. One way to solve this problem is by moving physician practices into VBC and to demonstrating that VBC is a bonus, not a penalty, and probably the only way to get back to the earnings they previously had. Also, when looking at hospital systems, investor-based hospitals performed significantly better during the pandemic. Innovative programs like the Accountable Care Organizations Realizing Equity, Access, and Community Health (ACO REACH) model are showing hospitals and physicians that the market is experiencing a technology shift, [...]

    Continue Reading



This Week in 340B: September 6 – 11, 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation.

Issues at Stake: Contract Pharmacy

  • The government appellee in a contract pharmacy case filed a response to the trade association appellant’s Rule 28(j) letter.
  • The government defendant filed an answer in a state contract pharmacy case.

Get more details on these 340B cases with the 340B Litigation Tracker, a subscription product from McDermott+Consulting.




STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm
U.S. News Law Firm of the Year 2022 Health Care Law